Injective Enables Pre-IPO Equity Trading, Revolutionizing Finance with Access to Private Companies’ Assets

Injective has launched a groundbreaking move, offering pre-IPO perpetual markets for companies like OpenAI through Helix Markets. This innovative platform facilitates the democratization of access to high-value private equity assets previously reserved for institutional investors, marking a significant shift towards on-chain finance. This exciting development comes as a result of Injective’s commitment to expanding the $13 trillion private equity market onto the blockchain, highlighted by a second ETF filing and record trading volumes exceeding $660 million in a single day, with Helix Markets leading the charge.